Sort   by:  
 Page size 
UnknownReport of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial.
Not available
S-EPMC9981330 | biostudies-literature
UnknownTherapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594 | biostudies-literature
UnknownNovel subtypes of severe COVID-19 respiratory failure based on biological heterogeneity: a secondary analysis of a randomized controlled trial.
Not available
S-EPMC10882728 | biostudies-literature
UnknownI-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operations.
Not available
S-EPMC9170797 | biostudies-literature
UnknownRosuvastatin for sepsis-associated acute respiratory distress syndrome.
Not available
S-EPMC4241052 | biostudies-literature
UnknownEvaluating Muscle Mass in Survivors of Acute Respiratory Distress Syndrome: A 1-Year Multicenter Longitudinal Study.
Not available
S-EPMC6051433 | biostudies-literature
UnknownSystematic data capture reduces the need for source data verification: exploratory analysis from a phase 2 multicenter randomized controlled platform trial.
Not available
S-EPMC12572212 | biostudies-literature
UnknownProspective Assessment of the Feasibility of a Trial of Low-Tidal Volume Ventilation for Patients with Acute Respiratory Failure.
Not available
S-EPMC6394119 | biostudies-literature
UnknownEarly Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
Not available
S-EPMC6741345 | biostudies-literature
UnknownRisk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa.
Not available
S-EPMC7499501 | biostudies-literature
Sort   by:  
 Page size